Akèy › Kansè fwa (Kasinòm epatoselilè) › Kalifòni › Orange
Etid klinik pou Kansè fwa (Kasinòm epatoselilè) nan Orange, CA
14 etid pou Kansè fwa (Kasinòm epatoselilè) ap chèche patisipan nan sit nan ak bò kote Orange (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
Ap rekriteFaz 1/2
- Research Facility, Orange
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Ap rekriteFaz 1/2
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
Ap rekriteFaz 2
- UC Irvine Health. Chao Family Comprehensive Cancer Center, Orange
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
Ap rekriteFaz 1/2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
Ap rekrite
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Ap rekriteFaz 1/2
- Children's Hospital of Orange County, Orange
Patient-Derived Xenografts to Reduce Cancer Health Disparities
Ap rekriteEtid obsèvasyon
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Ap rekriteFaz 3
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Ap rekriteFaz 1
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
Ap rekriteFaz 1/2
- Children's Hospital Orange County, Orange
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma
Ap rekriteFaz 2
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
Ap rekriteFaz 1/2
- University of California Irvine Medical Center, Orange
Combination of TATE and PD-1 Inhibitor in Liver Cancer
Ap rekriteFaz 2
- University of California, Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Orange
Etid Kansè fwa (Kasinòm epatoselilè) nan lòt vil
- Houston, TX31 etid
- New York City, NY24 etid
- Dallas, TX19 etid
- Los Angeles, CA19 etid
- Boston, MA18 etid
- Cleveland, OH18 etid
- Philadelphia, PA16 etid
- Chicago, IL16 etid
- Pittsburgh, PA15 etid
- San Francisco, CA14 etid
- Jacksonville, FL14 etid
- San Antonio, TX13 etid
Lòt etid nan Orange
- Kansè Poumon ki pa ti selil25 etid
- Kansè Metastatik20 etid
- Kansè kolorektal16 etid
- Kansè ovè16 etid
- Kansè pankreyas15 etid
- Melanom14 etid
- Kansè nan tete14 etid
- Kansè poumon14 etid
- Kansè pwostat14 etid
- Kansè lestomak13 etid
- Kansè (tout kalite)13 etid
- Leksemi mieloïd egi13 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.